ProShares UltraPro QQQ ETF vs Veeva Systems — how do they compare? ProShares UltraPro QQQ ETF trades at $71.29, while Veeva Systems trades at $261 (market cap $42.88B). Which is the better fit depends on your goals.
| TQQQ | VEEV | |
|---|---|---|
Sector | Leveraged / Inverse | Technology |
52-Week High | $87.22 | $306.22 |
52-Week Low | $37.89 | $151.43 |
Market Cap | — | $42.88B |
Enterprise Value | — | $35.79B |
Signals from Pluang's Aura AI — not financial advice
TQQQ, a 3x leveraged ETF tracking the Nasdaq-100, trades at $72.16, down 0.29% on the day. Technical indicators show a bullish trend with strong moving average support, while oscillators are neutral. Recent news highlights its amplified returns during the AI boom but warns of structural costs like volatility decay. The ETF's performance is closely tied to large-cap tech earnings and market sentiment.
The outlook for TQQQ hinges on continued tech sector strength, particularly AI-driven growth, but risks include high volatility and decay from daily rebalancing. Investors face amplified gains or losses, making it suitable only for those comfortable with significant risk. Monitoring underlying index performance and tech earnings is critical for timing entries and exits.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
TQQQ is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the Nasdaq-100 Index. It is one of the most liquid and actively traded instruments in the market, designed for sophisticated traders to amplify short-term bullish exposure to large-cap non-financial growth stocks, predominantly in the technology and communication sectors.
Read more on TQQQ →Veeva Systems provides cloud software, data, and services for the life sciences industry. Its applications support functions across clinical research, regulatory operations, quality, safety, and commercial teams.
Read more on VEEV →